3 products found
Celixir plc Products
-
Pipeline
Innovation is at the heart of Celixir. Our unique technology platform drives in-house discovery and manufacturing. We have more than 20 tissue-specific regenerative medicines in our pipeline, which is unprecedented in the field of regenerative medicine. At Celixir, our R&D activities are focused on bringing life-saving regenerative medicines to market.
-
Celixir Heartcel - Immunomodulatory Progenitor Cells
PHASE 2 : Our first investigational cardiac regenerative medicine consists of iMP cells. iMP cells are designed to treat patients with ischaemic heart disease – ischaemic cardiomyopathy – undergoing coronary artery bypass graft (CABG). They are injected around cardiac scar tissue via a single application during bypass ...
-
Celixir Tendoncel - Platelet Lysate-Based Therapy Cells
PHASE 3 : Our investigational topical gel containing platelet lysate is capable of regenerating injured tendons near the surface of the ...
-
Celixir Myocardion - Progenitor Cells of Mesodermal Lineage
Clinical trial ready : PML cells are being investigated as a treatment for patients with mild to moderate heart ...